-
881
A Multicentre Randomized Controlled Trial of Recombinant Interferon-Alpha-2a in the Treatment of Patients with Chronic Hepatitis C
Published 1997-01-01“…Sixty-one chronic hepatitis C patients were randomly assigned to receive either 6x106 or 9x106 U of recombinant interferon-alpha-2a (IFNα-2a) six days a week for the first two weeks of treatment, followed in both cases by 6x106 U three days a week for the next 22 weeks. …”
Get full text
Article -
882
Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis
Published 2022-01-01“…Circulating cytokines and chemokines play critical roles in hepatitis B virus (HBV) infection. Here, we explored the effects of proinflammatory and anti-inflammatory effector molecules on HBV progression, e antigen seroconversion, and liver function. …”
Get full text
Article -
883
-
884
-
885
-
886
Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study
Published 2019-01-01“…To investigate the efficacy of telbivudine (LdT) in blocking mother-to-child transmission (MTCT) of hepatitis B virus (HBV) during late pregnancy. Methods. …”
Get full text
Article -
887
Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein.
Published 2025-01-01“…Hepatitis B virus (HBV) X protein (HBx) is a key factor for regulating viral transcription and replication. …”
Get full text
Article -
888
Animal-based evidence supports protective activity of bioengineered silver and gold nanomaterials on hepatic and renal function profile parameters
Published 2025-01-01“…This review presents the novelty of bioengineered NPs as potential therapeutic agents for hepatic and renal protection while highlighting the need for further research into their pharmacokinetics and pharmacodynamics to advance clinical translation.…”
Get full text
Article -
889
FXR activation reduces the formation of macrophage foam cells and atherosclerotic plaque, possibly by down regulating hepatic lipase in macrophages
Published 2025-02-01Subjects: Get full text
Article -
890
-
891
Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
Published 2012-11-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
892
Positive hepatitis B surface antigen leads to a decrease in ovarian reserve in infertile patients receiving first in vitro fertilization treatment
Published 2025-02-01Subjects: “…Hepatitis B virus…”
Get full text
Article -
893
Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study
Published 2014-07-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
894
-
895
Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
Published 2011-06-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
896
Identification of multiple complications as independent risk factors associated with 1-, 3-, and 5-year mortality in hepatitis B-associated cirrhosis patients
Published 2025-02-01Subjects: “…Hepatitis B…”
Get full text
Article -
897
SUPPRESSION OF SUBGENOMIC HEPATITIS C VIRUS RNA REPLICON REPLICATION IN Huh-7 CELLS BY THE NS3 PROTEASE INHIBITOR SCH5030334: A STOCHASTIC MATHEMATICAL MODEL
Published 2014-12-01Subjects: “…hepatitis c virus…”
Get full text
Article -
898
DETECCIÓN DEL GENOMA DEL VIRUS DE LA HEPATITIS E (VHE) EN MUESTRAS DE HECES DE CERDOS EN PLANTAS DE BENEFICIO DE ANTIOQUIA, COLOMBIA
Published 2014-01-01Subjects: “…virus de la hepatitis e…”
Get full text
Article -
899
-
900
Positive association between proinsulin and fatty liver index in people with type 2 diabetes
Published 2024-02-01Subjects: Get full text
Article